Pangulong DU30 nais papanagutin ang Sanofi | Bandera

Pangulong DU30 nais papanagutin ang Sanofi

- December 12, 2017 - 03:39 PM

NAIS ni Pangulong Duterte na papanagutin ang Sanofi kaugnay ng kontrobersiyal na dengue vaccine na Dengvaxia.

Sa isang briefing, sinabi ni Presidential Spokesperson Harry Roque na suportado ni Duterte ang rekomendasyon ng Department of Health (DOH) na habulin ang Sanofi.

“He stands by the recommendation of the DOH to hold Sanofi responsible. We want, by way of mere — by way of minimum, a refund of what we have paid already for the Dengvaxia, sabi ni Roque kaugnay naman ng P3.5 bilyong dengue vaccine na binili sa Sanofi.

Idinagdag ni Roque na hinihintay na ni Duterte ang resulta ng isinasagawang imbestigasyon ng Senado kaugnay ng Dengvaxia.

“And he has promised that after investigation are — has been or have been conducted both by the Senate and the Department of Justice — that he will run after all individuals who may have criminal culpability for this ‘no,” ayon pa kay Roque.

Ani Roque, malinaw na may itinagong impormasyon sa publiko ang Sanofi.

He wants a refund of what we had paid because there was concealment of a material fact and that is that children who have not developed dengue may acquire the disease three to six years after the vaccination. That was not a known fact when government decided to embark on the vaccination program,”  sabi ni Roque.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Bandera. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

What's trending